Carisoprodol

Product NDC
0143-1176
11-digit product format
001431176
Labeler code
0143
Product ID
0143-1176_d10e9acd-7454-4b4f-9b51-60fc91f95dcb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carisoprodol
Dosage form
TABLET
Route
ORAL
Labeler
Hikma Pharmaceuticals USA Inc.
Application
ANDA040124
Marketing category
ANDA
Marketing start
1996-01-24
Marketing end
2022-12-31
Substance
CARISOPRODOL
Active strength
350 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
780d53a1-1665-e26e-d112-85333c0c8a2eProduct name520220516
2a21311a-89e2-0e83-2ebd-117f9798b2b2Product name120140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94eProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0143-1176-01EA - Each0143-1176d298f9b3-cc8d-486c-8f0d-33da965b2e9d12012-07-24
0143-1176-05EA - Each0143-117683f81d16-bcf1-42a5-8d3b-5fb3e558e2cf12012-07-24
0143-1176-10EA - Each0143-117646b008b0-acbe-4ee4-b83b-9cb1bd7ac94212012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
.GAMMA.-AMINOBUTYRIC ACIDACTIVE INGREDIENT2ACZ6IPC6IPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
CARISOPRODOLACTIVE INGREDIENT21925K482HPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
.GAMMA.-AMINOBUTYRIC ACIDACTIVE MOIETY2ACZ6IPC6IPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
CARISOPRODOLACTIVE MOIETY21925K482HPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
GELATININACTIVE INGREDIENT2G86QN327LPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
POVIDONEINACTIVE INGREDIENTFZ989GH94EPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APPRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC]18
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
METHYLCELLULOSE (100 CPS)INACTIVE INGREDIENT4GFU244C4JCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
POVIDONEINACTIVE INGREDIENTFZ989GH94ECARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCARISOPRODOL TABLET [KELTMAN PHARMACEUTICALS INC.]5
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
METHYLCELLULOSE (100 CPS)INACTIVE INGREDIENT4GFU244C4JCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.]4
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [STAT RX USA LLC]3
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [STAT RX USA LLC]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCARISOPRODOL TABLET [STAT RX USA LLC]3
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XCARISOPRODOL TABLET [STAT RX USA LLC]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CARISOPRODOL TABLET [STAT RX USA LLC]3
METHYLCELLULOSE (100 CPS)INACTIVE INGREDIENT4GFU244C4JCARISOPRODOL TABLET [STAT RX USA LLC]3
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCARISOPRODOL TABLET [STAT RX USA LLC]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CARISOPRODOL TABLET [STAT RX USA LLC]3
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCARISOPRODOL TABLET [STAT RX USA LLC]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CARISOPRODOL TABLET [STAT RX USA LLC]3
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCARISOPRODOL TABLET [STAT RX USA LLC]3
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [STAT RX USA LLC]1
CARISOPRODOLACTIVE INGREDIENT21925K482HCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [STAT RX USA LLC]1
CARISOPRODOLACTIVE MOIETY21925K482HCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCARISOPRODOL TABLET [STAT RX USA LLC]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XCARISOPRODOL TABLET [STAT RX USA LLC]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CARISOPRODOL TABLET [STAT RX USA LLC]1
METHYLCELLULOSE (100 CPS)INACTIVE INGREDIENT4GFU244C4JCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ECARISOPRODOL TABLET [STAT RX USA LLC]1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CARISOPRODOL TABLET [STAT RX USA LLC]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCARISOPRODOL TABLET [STAT RX USA LLC]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CARISOPRODOL TABLET [STAT RX USA LLC]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJCARISOPRODOL TABLET [STAT RX USA LLC]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCARISOPRODOL TABLET [AIDAREX PHARMACEUTICALS LLC]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCARISOPRODOL TABLET [STAT RX USA LLC]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197446carisoprodol 350 MG Oral TabletPSN99265e39-af23-43eb-a552-305f0a218fdf18
197446carisoprodol 350 MG Oral TabletSCD99265e39-af23-43eb-a552-305f0a218fdf18
197446carisoprodol 350 MG Oral TabletPSN9e517e32-d5ac-438d-b613-306e6aa6c45b5
197446carisoprodol 350 MG Oral TabletSCD9e517e32-d5ac-438d-b613-306e6aa6c45b5
197446carisoprodol 350 MG Oral TabletPSN037618dc-8aed-4a96-93a5-69971f2a37424
197446carisoprodol 350 MG Oral TabletSCD037618dc-8aed-4a96-93a5-69971f2a37424
197446carisoprodol 350 MG Oral TabletPSN6b9532e9-69e0-4e87-9e68-c6ec113ff8b33
197446carisoprodol 350 MG Oral TabletSCD6b9532e9-69e0-4e87-9e68-c6ec113ff8b33
197446carisoprodol 350 MG Oral TabletPSN11f93bdb-0855-4609-b6e4-700f10a639af1
197446carisoprodol 350 MG Oral TabletPSN989b3762-6917-4e3f-9010-3236656456261
197446carisoprodol 350 MG Oral TabletSCD11f93bdb-0855-4609-b6e4-700f10a639af1
197446carisoprodol 350 MG Oral TabletSCD989b3762-6917-4e3f-9010-3236656456261

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0143-1176-0100143117601100 TABLET in 1 BOTTLE, PLASTIC (0143-1176-01) 100 tablet1996-01-242022-12-31NoNoCurrent
0143-1176-0500143117605500 TABLET in 1 BOTTLE, PLASTIC (0143-1176-05) 500 tablet1996-01-242022-12-31NoNoCurrent
0143-1176-10001431176101000 TABLET in 1 BOTTLE, PLASTIC (0143-1176-10) 1000 tablet1996-01-242022-12-31NoNoCurrent